Reporting rate of adverse drug reactions increased gradually over the years in Turkey in parallel to awareness activities on drug safety.

In Turkey, the reporting rate of adverse drug reactions was higher in females and elderly patients.

The number of ADRs reported per million boxes of drug consumption was highest for antineoplastic and immunomodulating agents.